Jonathan Zalevsky, Ph.D.
About Jonathan Zalevsky, Ph.D.
Jonathan Zalevsky, Ph.D., serves as the Chief Research & Development Officer, having joined the company in 2015 and previously holding the position of Chief Scientific Officer since 2017.
Jonathan Zalevsky, Ph.D. - Chief Research & Development Officer Profile
Jonathan Zalevsky, Ph.D., currently serves as the Chief Research & Development Officer. He joined the company in 2015, initially serving as Chief Scientific Officer from 2017 before taking on his current role. His expertise and leadership have played a critical role in steering the company's research and development initiatives.
Jonathan Zalevsky Education and Background
Jonathan Zalevsky obtained a Ph.D. in Biochemistry through the Tetrad Program at the University of California, San Francisco. Prior to his doctoral studies, he earned dual Bachelor of Science degrees in Biochemistry and Molecular, Cellular, and Developmental Biology from the University of Colorado at Boulder. This strong educational foundation has been fundamental to his career in pharmaceutical research and development.
Jonathan Zalevsky's Career at Takeda Pharmaceuticals
Before joining his current company, Jonathan Zalevsky held the position of Global Vice President and Head of the Inflammation Drug Discovery Unit at Takeda Pharmaceuticals. His role involved overseeing critical projects aimed at discovering and developing treatments for inflammatory diseases, bringing new insights and innovations to the field.
Jonathan Zalevsky's Role at Xencor
At Xencor, Jonathan Zalevsky was responsible for overseeing the discovery and development of the company's first four clinical-stage assets. His contributions were pivotal in advancing Xencor's initial portfolio, highlighting his capability in managing complex drug development projects and leading scientific teams.